Science Explorer Back to mapMap
Discussion
Researcher · Klinikum Würzburg Mitte · Germany

Jens Kern

Jens Kern publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Cancer Research, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Lung Cancer Research Studies.

OpenAlex
World rank
#3,320,097
of 7,710,434 ranked researchers
Rank in Germany
#165,524
of 364,343
Works
26
Citations
378
Citations per work
14.5
h-index
6
i10-index 5Top 84% in Oncology
Jens Kern

What does Jens Kern research?

Jens Kern's work is mostly in Medicine (74%), Biochemistry, Genetics and Molecular Biology (15%).

Health Sciences: 19 works · 73.9% of their workMedicine: 19 works · 73.9% of their workOncology: 9 works · 35.6% of their workPulmonary and Respiratory Medicine: 9 works · 35.6% of their workHepatology: 1 works · 2.7% of their workLife Sciences: 4 works · 15.0% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 15.0% of their workCancer Research: 2 works · 6.8% of their workMolecular Biology: 1 works · 5.5% of their workEndocrinology: 1 works · 2.7% of their workEverything else: 3 works · 11.1% of their workTHEIR WORKJens Kern26works
Life Sciences15%Health Sciences74%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1973.9%
    1. Biochemistry, Genetics and Molecular Biology415.0%
  3. Everything else311.1%
  1. 1Oncology36% of their works
  2. 2Pulmonary and Respiratory Medicine36% of their works
  3. 3Cancer Research7% of their works
  4. 4Molecular Biology6% of their works
  5. 5Endocrinology3% of their works
  6. 6Hepatology3% of their works

Research topics

Which keywords describe Jens Kern's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, ALK Inhibitors, EGFR Mutations, Chemotherapy, Tumor Microenvironment, Immunotherapy and Immune Checkpoint Blockade.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Targeted Therapy303 topics
  2. Clinical Trials252 topics
  3. ALK Inhibitors181 topic
  4. EGFR Mutations181 topic
  5. Chemotherapy163 topics
  6. Tumor Microenvironment122 topics
  7. Immunotherapy112 topics
  8. Immune Checkpoint Blockade81 topic
  9. PD-1 and PD-L181 topic
  10. Genomic Profiles71 topic
  11. Small-Cell Lung Cancer71 topic
  12. CT Screening51 topic
  13. Cancer Genomics51 topic
  14. Lung Cancer51 topic
  15. Mutational Signatures51 topic
  16. Pancreatic Cancer41 topic
  17. Surgical Complications41 topic
  18. BRAF gene21 topic
  19. Hepatocellular Carcinoma21 topic
  20. Liver Cancer21 topic
  21. MAP Kinase21 topic

Where does Jens Kern work?

Jens Kern's main affiliation in the publication record is Klinikum Würzburg Mitte, Germany.

How many publications and citations does Jens Kern have?

OpenAlex counts 26 works and 378 citations for Jens Kern, an h-index of 6, ranking #3,320,097 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jens Kern. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.